Karagodin Ilya, Aba-Omer Omer, Sparapani Rodney, Strande Jennifer L
Department of Medicine, Medical College of Wisconsin, 9200 Wisconsin Ave, Milwaukee, WI, 53226, USA.
Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI, USA.
BMC Cardiovasc Disord. 2017 Feb 14;17(1):62. doi: 10.1186/s12872-017-0490-9.
Identifying which patients with diastolic dysfunction will progress to heart failure with preserved ejection fraction (HFpEF) remains challenging. The goal of this study is to determine whether increased vascular stiffness as identified on 2D transthoracic echocardiography (TTE) serves as a biomarker for the development of HFpEF in patients with diastolic dysfunction.
The study design is a matched retrospective case-control study. Subjects with diastolic dysfunction were divided into two groups based on whether they had a clinical diagnosis of HFpEF. The two groups were matched based on age, gender, race and body surface area, resulting in 77 matched pairs (n = 154). Data from the first TTE that documented diastolic dysfunction prior to the development of HFpEF was extracted along with baseline demographic and clinical data. Indices of vascular stiffness were measured and compared. A sub-group analysis was performed to compare diabetic subjects in Group 1 (n = 43) to those in Group 2 (n = 21).
Group 1 had significantly decreased aortic distensibility as measured on the initial TTE when compared to Group 2 (1.9 ± 1.0 vs. 2.8 ± 1.8 cmdyne10, p = 0.01). In the diabetic subset, Group 1 had significantly less aortic strain (6.9 ± 3.3 vs. 9.7 ± 5.6%, p = 0.02) and aortic distensibility (1.8 ± 1.0 vs. 3.5 ± 2.6 cmdyne10, p = 0.02) compared to Group 2. Other indices of vascular stiffness did not differ significantly between groups.
This study demonstrates that increased proximal aortic stiffness is associated with the development of HFpEF in patients with asymptomatic diastolic dysfunction. Larger prospective studies are needed to further investigate this relationship.
确定哪些舒张功能障碍患者会进展为射血分数保留的心力衰竭(HFpEF)仍然具有挑战性。本研究的目的是确定二维经胸超声心动图(TTE)所显示的血管僵硬度增加是否可作为舒张功能障碍患者发生HFpEF的生物标志物。
本研究设计为配对回顾性病例对照研究。舒张功能障碍患者根据是否有HFpEF的临床诊断分为两组。两组根据年龄、性别、种族和体表面积进行配对,共形成77对匹配组(n = 154)。提取HFpEF发生前记录舒张功能障碍的首次TTE数据以及基线人口统计学和临床数据。测量并比较血管僵硬度指标。进行亚组分析,比较第1组(n = 43)和第2组(n = 21)中的糖尿病患者。
与第2组相比,第1组在初始TTE测量时主动脉扩张性显著降低(1.9±1.0 vs. 2.8±1.8 cm/dyne×10,p = 0.01)。在糖尿病亚组中,与第2组相比,第1组的主动脉应变显著更低(6.9±3.3 vs. 9.7±5.6%,p = 0.02),主动脉扩张性也更低(1.8±1.0 vs. 3.5±2.6 cm/dyne×10,p = 0.02)。两组之间其他血管僵硬度指标无显著差异。
本研究表明,近端主动脉僵硬度增加与无症状舒张功能障碍患者发生HFpEF有关。需要更大规模的前瞻性研究来进一步探究这种关系。